Cargando…
Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo
PURPOSE: Molecular imaging techniques visualise biomarkers for both drug development and personalised medicine. In this field, Cherenkov luminescence imaging (CLI) seems to be very attractive by allowing imaging with clinical PET radiotracers with high-throughput capabilities. In this context, we de...
Autores principales: | Desvaux, Emiko, Courteau, Alan, Bellaye, Pierre-Simon, Guillemin, Mélanie, Drouet, Camille, Walker, Paul, Collin, Bertrand, Decréau, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301908/ https://www.ncbi.nlm.nih.gov/pubmed/30574662 http://dx.doi.org/10.1186/s13550-018-0464-7 |
Ejemplares similares
-
Redshifted Cherenkov Radiation for in vivo Imaging: Coupling Cherenkov Radiation Energy Transfer to multiple Förster Resonance Energy Transfers
por: Bernhard, Yann, et al.
Publicado: (2017) -
Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia
por: Dias, Alexandre M. M., et al.
Publicado: (2022) -
[(123)I]MIBG is a better early marker of anthracycline cardiotoxicity than [(18)F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study
por: Oudot, Alexandra, et al.
Publicado: (2021) -
Cherenkov luminescence imaging of shallow sources in semitransparent media
por: Komarov, Sergey, et al.
Publicado: (2019) -
[(18)F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [(18)F]FDG PET/CT approach
por: Tanguy, Julie, et al.
Publicado: (2021)